He Min, Qin Weishan, Qin Zongshi, Zhao Changqing
Department of Ophthalmology, Shanxi Medical University Second Affiliated Hospital, No. 382, Wuyi Road, Taiyuan, 030001, Shanxi, People's Republic of China.
Department of Acupuncture and Neurology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, People's Republic of China.
Eur J Med Res. 2022 Apr 25;27(1):58. doi: 10.1186/s40001-022-00682-3.
In this study, we attempted to assess the efficacy and safety of acupuncture for allergic rhinitis (AR), and to test the robustness of the estimated effects.
The Cochrane methodology standard was followed to conduct this systematic review. Randomized controlled trials (RCTs) comparing acupuncture with other therapies for AR were included. Furthermore, trial sequential analysis was conducted to test the robustness of pooled results. Thirty trials with 4413 participants were included.
Acupuncture improved the nasal symptoms on Total Nasal Symptom Score (TNSS) and quality of life measured by Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) in adults with AR, compared to acupuncture with no intervention. Acupuncture was also shown to be more effective than sham acupuncture for nasal symptom (RQLQ subscale, n = 489, MD - 0.60, 95% CI - 1.16 to - 0.04) and quality of life (RQLQ, n = 248, - 8.47 95% CI - 14.91, - 2.03). No clear difference was observed between acupuncture and cetirizine or loratadine. Interestingly, trial sequential analysis (TSA) failed to confirm the aforementioned results. The effect of acupuncture for children/adolescents with AR remains unclear due to insufficient data. The performance bias and attrition bias are serious in most studies that were included. Selection bias may also have affected the quality of the evidence.
Acupuncture may have an advantage over no intervention and sham acupuncture in improving nasal symptoms and quality of life for adults with AR. The effect of acupuncture and cetirizine or loratadine for AR may be similar. Additional trials are necessary to confirm these results.
在本研究中,我们试图评估针灸治疗过敏性鼻炎(AR)的疗效和安全性,并检验估计效应的稳健性。
遵循Cochrane方法标准进行本系统评价。纳入比较针灸与其他治疗AR方法的随机对照试验(RCT)。此外,进行试验序贯分析以检验汇总结果的稳健性。纳入了30项试验,共4413名参与者。
与未干预的针灸相比,针灸改善了AR成年患者的总鼻症状评分(TNSS)鼻症状及通过鼻结膜炎生活质量问卷(RQLQ)测量的生活质量。针灸在改善鼻症状(RQLQ子量表,n = 489,MD -0.60,95%CI -1.16至-0.04)和生活质量(RQLQ,n = 248,-8.47 95%CI -14.91,-2.03)方面也显示比假针灸更有效。在针灸与西替利嗪或氯雷他定之间未观察到明显差异。有趣的是,试验序贯分析(TSA)未能证实上述结果。由于数据不足,针灸对儿童/青少年AR的疗效仍不清楚。纳入的大多数研究中执行偏倚和失访偏倚严重。选择偏倚也可能影响了证据质量。
在改善AR成年患者的鼻症状和生活质量方面,针灸可能比不干预和假针灸更具优势。针灸与西替利嗪或氯雷他定治疗AR的效果可能相似。需要更多试验来证实这些结果。